Catalyst Pharmaceuticals, Inc.
CFO
7 appearances
Latest appearance 2023-06-30
Alicia Grande
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alicia Grande
Earlier roles on record: CFO at Catalyst Pharmaceuticals, Inc. until December 31, 2023. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed December 7, 2023 that Alicia Grande retired as Chief Financial Officer, effective December 31, 2023. Alicia Grande has spoken on 7 earnings calls across 1 company, most recently for Catalyst Pharmaceuticals, Inc. on June 30, 2023.
“On December 1, 2023, Alicia Grande, the Chief Financial Officer (“CFO”) of Catalyst Pharmaceuticals, Inc. (the “Company”) informed the Company of her intent to retire as the Company’s CFO at the end of 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Catalyst Pharmaceuticals, Inc.
CFO
Source not stated
Start not stated–2023-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q2 FY2023 Earnings Call
Catalyst Pharmaceuticals, Inc.
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q1 FY2023 Earnings Call
Catalyst Pharmaceuticals, Inc.
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q4 FY2022 Earnings Call
Catalyst Pharmaceuticals, Inc.
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q4 FY2021 Earnings Call
Catalyst Pharmaceuticals, Inc.
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q1 FY2021 Earnings Call
Catalyst Pharmaceuticals, Inc.
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q3 FY2020 Earnings Call
Catalyst Pharmaceuticals, Inc.
-
Earnings call
Catalyst Pharmaceuticals, Inc. Q1 FY2020 Earnings Call
Catalyst Pharmaceuticals, Inc.